TriSalus Life Sciences Secures Up to $50M in Debt Financing from OrbiMed for TriNav® Infusion System Growth

TriSalus Life Sciences Inc. (Nasdaq: TLSI) has finalized a debt financing agreement of up to $50 million with OrbiMed, a leading healthcare investment firm. This capital infusion aims to offer financial flexibility, enabling the company to execute strategic expansion initiatives…

Read MoreTriSalus Life Sciences Secures Up to $50M in Debt Financing from OrbiMed for TriNav® Infusion System Growth

ATLATL Scientific and Miltenyi Biotec Forge 5-Year Biotech Innovation Partnership

ATLATL Scientific and Miltenyi Biotec mark a significant milestone with their five-year partnership, showcasing a journey of collaboration and innovation in the biotech sector. This dynamic alliance has flourished, driving notable advancements in biotechnology. Since its inception, the partnership has…

Read MoreATLATL Scientific and Miltenyi Biotec Forge 5-Year Biotech Innovation Partnership

OACHC and AndHealth Collaborate for Specialty Care + Pharmacy in Ohio Community Health Centers

AndHealth has teamed up with the Ohio Association of Community Health Centers (OACHC) to introduce a statewide Whole-Person Community Care Model for Ohio’s Community Health Centers (CHCs) and their patients. With this partnership, Ohio’s 59 CHCs, constituting the state’s largest…

Read MoreOACHC and AndHealth Collaborate for Specialty Care + Pharmacy in Ohio Community Health Centers